It is used for the management of chronic COPD and it can be used as a rescue inhaler as well. It is available as a 45 mcg aerosol or a nebulizer (0.31 mg/3 mL, 0.63 mg/3 mL, 1.25 mg/3 mL, or 1.25 ...

Extrafine single inhaler triple therapy is effective among patients with COPD who were previously treated with multiple-inhaler triple therapy.

Patients with asthma and COPD routinely switch from pressurized metered-dose inhalers (pMDIs) to dry powder inhalers (DPIs) and vice versa.

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to reduce COPD exacerbations in some patients whose symptoms aren’t adequately controlled with inhaled medicines.

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions. In ...

Two posters presented at the CHEST 2024 annual meeting underscore the importance of early identification and treatment of ...

A new analysis that compares two common inhalers for patients suffering from chronic obstructive pulmonary disease (COPD) finds that one reduces respiratory-related hospitalizations and ...

Purpose: Pharmacokinetic and safety data related to the use of inhaled insulin for the management of diabetes mellitus are discussed. The various pulmonary insulin delivery systems under ...

Digital inhalers improve adherence but have not significantly impacted patient outcomes; affordability and education are crucial. Digital technologies effectively deliver pulmonary rehabilitation ...

“We’re trying to treat conditions like asthma and COPD with these inhalers, and we’re actually making it harder to breathe,” said Jyothi Tirumalasetty, a clinical assistant professor at ...

Analysts expect the partners’ first-mover advantage, clinical data and existing presence in lung disease to translate into ...